Equity Profile

ACAD

ACADIA Pharmaceuticals Inc.

Health CareBiotechnology$4.4B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

ACADIA Pharmaceuticals Inc. is a biotechnology company focused on developing innovative therapies for central nervous system disorders....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its expenses relative to its revenues.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and drive future profitability.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ACAD Q2-2026 Earnings Preview

Context

Company Snapshot

ACADIA Pharmaceuticals Inc. is a biotechnology company focused on developing innovative therapies for central nervous system disorders. With a market cap of $4 billion, its work is particularly relevant as the healthcare sector increasingly emphasizes mental health treatments and neurological conditions.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+226.66%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, ACADIA reported an EPS of $0.02, which was below the expected $0.04, leading to a stock decline of 3.89% the following day. The company has shown a strong history of beating earnings expectations, but this quarter's miss raised concerns.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as ACADIA has a strong track record of beating earnings estimates, but the recent miss has created uncertainty. Investors will be watching closely to see if the company can return to its previous performance levels.

Bull Case

If ACADIA can report better-than-expected EPS and show strong revenue growth, it could restore investor confidence and lead to a positive stock reaction.

Bear Case

Conversely, if the company misses expectations again or fails to provide clear guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the significant miss last quarter, the market will be closely watching for a rebound in EPS to regain confidence.

How is the company performing in terms of revenue growth?

Revenue growth is critical for assessing the company's future prospects, especially after a disappointing quarter.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly cautious following the last quarter's miss, underestimating ACADIA's potential for a strong recovery in EPS and revenue growth.

Supporting Evidence

The company's historical EPS beat rate of 88% suggests a strong likelihood of outperforming expectations.

Options are pricing a 10.63% move, indicating that traders expect significant volatility, which could favor a positive outcome.

Key Risk

If the EPS comes in above $0.04, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether ACADIA can recover from its recent earnings miss and demonstrate solid growth.

Bull Confirmed If

Reporting an EPS of $0.04 or higher would confirm the bull case and indicate a return to profitability.

Bear Confirmed If

An EPS below $0.02 would confirm the bear case and raise concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±10.63%

Historical Avg

±2.2%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±10.6% while ACAD has averaged ±2.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

33.8%

Calls (134K)P/C Ratio: 0.05Puts (500)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ACADIA beats expectations, history suggests a potential stock increase of around 1.98%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 3.89%, as seen in the previous quarter, raising concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or pipeline advancements.
2Management's commentary on revenue growth strategies.
3Insights into market conditions impacting demand for their products.
4Guidance on future earnings expectations.
5Responses to analyst questions regarding the recent earnings miss.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

ACADIA Pharmaceuticals Inc. is a biotechnology company focused on developing innovative therapies for central nervous system disorders....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its expenses relative to its revenues.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and drive future profitability.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ACAD Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+226.66%

Avg Stock Reaction

+1.25%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If ACADIA can report better-than-expected EPS and show strong revenue growth, it could restore investor confidence and lead to a positive stock reaction.

Bear Case

Conversely, if the company misses expectations again or fails to provide clear guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the significant miss last quarter, the market will be closely watching for a rebound in EPS to regain confidence.

How is the company performing in terms of revenue growth?

Revenue growth is critical for assessing the company's future prospects, especially after a disappointing quarter.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly cautious following the last quarter's miss, underestimating ACADIA's potential for a strong recovery in EPS and revenue growth.

Supporting Evidence

The company's historical EPS beat rate of 88% suggests a strong likelihood of outperforming expectations.

Options are pricing a 10.63% move, indicating that traders expect significant volatility, which could favor a positive outcome.

Key Risk

If the EPS comes in above $0.04, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether ACADIA can recover from its recent earnings miss and demonstrate solid growth.

Bull Confirmed If

Reporting an EPS of $0.04 or higher would confirm the bull case and indicate a return to profitability.

Bear Confirmed If

An EPS below $0.02 would confirm the bear case and raise concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±10.63%

Historical Avg

±2.2%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±10.6% while ACAD has averaged ±2.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

33.8%

Calls (134K)P/C Ratio: 0.05Puts (500)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ACADIA beats expectations, history suggests a potential stock increase of around 1.98%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 3.89%, as seen in the previous quarter, raising concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or pipeline advancements.
2Management's commentary on revenue growth strategies.
3Insights into market conditions impacting demand for their products.
4Guidance on future earnings expectations.
5Responses to analyst questions regarding the recent earnings miss.